Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma
Related Experiment Video
Updated: Jun 12, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Linda Hanlon1, Jacqueline L Avila, Renée M Demarest
1Molecular and Cellular Oncogenesis Program, The Wistar Institute, 3601Spruce Street, Philadelphia, PA 19104, USA.
Abstract:
K-ras is the most commonly mutated oncogene in pancreatic cancer and its activation in murine models is sufficient to recapitulate the spectrum of lesions seen in human pancreatic ductal adenocarcinoma (PDAC). Recent studies suggest that Notch receptor signaling becomes reactivated in a subset of PDACs, leading to the hypothesis that Notch1 functions as an oncogene in this setting. To determine whether Notch1 is required for K-ras-induced tumorigenesis, we used a mouse model in which an oncogenic allele of K-ras is activated and Notch1 is deleted simultaneously in the pancreas. Unexpectedly, the loss of Notch1 in this model resulted in increased tumor incidence and progression, implying that Notch1 can function as a tumor suppressor gene in PDAC.
Insights
Notch1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma (PDAC). Loss of Notch1 accelerates K-ras-induced PDAC development, contrary to previous hypotheses.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- K-ras mutations are prevalent in pancreatic cancer, driving tumorigenesis.
- Notch1 signaling reactivation is observed in some pancreatic ductal adenocarcinoma (PDAC) cases.
- Notch1 was hypothesized to function as an oncogene in PDAC.
Purpose of the Study:
- To investigate the role of Notch1 in K-ras-driven pancreatic tumorigenesis.
- To determine if Notch1 is essential for the development of PDAC.
Main Methods:
- Utilized a mouse model with simultaneous activation of oncogenic K-ras and deletion of Notch1 in the pancreas.
- Observed tumor incidence and progression in the developed mouse model.
Main Results:
- Loss of Notch1 led to increased tumor incidence.
- Notch1 deletion accelerated PDAC progression in the K-ras-driven model.
- Findings contradict the hypothesis of Notch1 acting as an oncogene in PDAC.
Conclusions:
- Notch1 functions as a tumor suppressor gene in pancreatic ductal adenocarcinoma.
- The role of Notch1 in PDAC is context-dependent and may vary with K-ras activation.
More Related Videos
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
The Ras Gene
Ras is a superfamily...
Canonical Wnt Signaling Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

